Kelly Lawrence W & Associates’s Vertex Pharmaceuticals VRTX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$261K Hold
585
0.07% 73
2025
Q4
$265K Hold
585
0.06% 74
2025
Q3
$229K Sell
585
-20
-3% -$8.36K 0.06% 80
2025
Q2
$269K Hold
605
0.07% 67
2025
Q1
$293K Hold
605
0.07% 71
2024
Q4
$244K Hold
605
0.06% 76
2024
Q3
$281K Sell
605
-700
-54% -$336K 0.06% 76
2024
Q2
$612K Sell
1,305
-153
-10% -$66.4K 0.14% 53
2024
Q1
$609K Sell
1,458
-10
-0.7% -$4.23K 0.14% 51
2023
Q4
$597K Hold
1,468
0.14% 53
2023
Q3
$510K Hold
1,468
0.14% 55
2023
Q2
$503K Hold
1,468
0.13% 56
2023
Q1
$463K Sell
1,468
-140
-9% -$42K 0.13% 59
2022
Q4
$464K Sell
1,608
-500
-24% -$152K 0.13% 58
2022
Q3
$610K Hold
2,108
0.17% 52
2022
Q2
$594K Hold
2,108
0.16% 53
2022
Q1
$550K Sell
2,108
-20
-0.9% -$4.75K 0.12% 55
2021
Q4
$468K Hold
2,128
0.09% 57
2021
Q3
$386K Hold
2,128
0.08% 59
2021
Q2
$429K Hold
2,128
0.09% 59
2021
Q1
$457K Buy
2,128
+1,341
+170% +$295K 0.11% 61
2020
Q4
$186K Sell
787
-1,766
-69% -$405K 0.07% 52
2020
Q3
$695K Buy
2,553
+20
+0.8% +$5.52K 0.21% 41
2020
Q2
$735K Sell
2,533
-5,195
-67% -$1.41M 0.15% 41
2020
Q1
$1.84M Sell
7,728
-550
-7% -$126K 0.45% 34
2019
Q4
$1.81M Sell
8,278
-545
-6% -$110K 0.28% 37
2019
Q3
$1.5M Sell
8,823
-215
-2% -$38K 0.25% 40
2019
Q2
$1.66M Sell
9,038
-735
-8% -$128K 0.28% 38
2019
Q1
$1.8M Sell
9,773
-1,429
-13% -$264K 0.32% 38
2018
Q4
$1.86M Sell
11,202
-125
-1% -$21.7K 0.4% 37
2018
Q3
$2.18M Sell
11,327
-500
-4% -$89K 0.36% 43
2018
Q2
$2.01M Sell
11,827
-1,520
-11% -$236K 0.37% 42
2018
Q1
$2.17M Sell
13,347
-6,955
-34% -$1.14M 0.41% 42
2017
Q4
$3.04M Sell
20,302
-405
-2% -$60K 0.56% 40
2017
Q3
$3.15M Sell
20,707
-380
-2% -$57.2K 0.6% 40
2017
Q2
$2.72M Hold
21,087
0.54% 42
2017
Q1
$2.31M Buy
21,087
+2
+0% +$176 0.48% 43
2016
Q4
$1.55M Sell
21,085
-77,080
-79% -$6.27M 0.34% 46
2016
Q3
$8.56M Sell
98,165
-20
-0% -$1.89K 1.83% 26
2016
Q2
$8.45M Buy
+98,185
New +$8.48M 1.95% 25

Other funds holding VRTX